Literature DB >> 24240927

Patient-specific stem cells and cardiovascular drug discovery.

Nicholas M Mordwinkin1, Andrew S Lee, Joseph C Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24240927      PMCID： PMC4033311          DOI： 10.1001/jama.2013.282409

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 2.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

3.  Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.

Authors:  Yama A Abassi; Biao Xi; Nan Li; Wei Ouyang; Alexander Seiler; Manfred Watzele; Ralf Kettenhofen; Heribert Bohlen; Andreas Ehlich; Eugen Kolossov; Xiaobo Wang; Xiao Xu
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

5.  Drugs in search of diseases.

Authors:  Steven M Paul; Freda Lewis-Hall
Journal:  Sci Transl Med       Date:  2013-05-22       Impact factor: 17.956

6.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

Review 7.  Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity.

Authors:  Nicola Ferri; Peter Siegl; Alberto Corsini; Joerg Herrmann; Amir Lerman; Renee Benghozi
Journal:  Pharmacol Ther       Date:  2013-03-15       Impact factor: 12.310

8.  Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Authors:  Ping Liang; Feng Lan; Andrew S Lee; Tingyu Gong; Veronica Sanchez-Freire; Yongming Wang; Sebastian Diecke; Karim Sallam; Joshua W Knowles; Paul J Wang; Patricia K Nguyen; Donald M Bers; Robert C Robbins; Joseph C Wu
Journal:  Circulation       Date:  2013-03-21       Impact factor: 29.690
  8 in total
  14 in total

Review 1.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 2.  Tracking gene and cell fate for therapeutic gain.

Authors:  Nigel G Kooreman; Julia D Ransohoff; Joseph C Wu
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

3.  Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems.

Authors:  Yosuke K Kurokawa; Rose T Yin; Michael R Shang; Venktesh S Shirure; Monica L Moya; Steven C George
Journal:  Tissue Eng Part C Methods       Date:  2017-08       Impact factor: 3.056

Review 4.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

Review 5.  Deranged sodium to sudden death.

Authors:  Colleen E Clancy; Ye Chen-Izu; Donald M Bers; Luiz Belardinelli; Penelope A Boyden; Laszlo Csernoch; Sanda Despa; Bernard Fermini; Livia C Hool; Leighton Izu; Robert S Kass; W Jonathan Lederer; William E Louch; Christoph Maack; Alicia Matiazzi; Zhilin Qu; Sridharan Rajamani; Crystal M Rippinger; Ole M Sejersted; Brian O'Rourke; James N Weiss; András Varró; Antonio Zaza
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

6.  Guidelines for translational research in heart failure.

Authors:  Enrique Lara-Pezzi; Philippe Menasché; Jean-Hugues Trouvin; Lina Badimón; John P A Ioannidis; Joseph C Wu; Joseph A Hill; Walter J Koch; Albert F De Felice; Peter de Waele; Valérie Steenwinckel; Roger J Hajjar; Andreas M Zeiher
Journal:  J Cardiovasc Transl Res       Date:  2015-01-21       Impact factor: 4.132

Review 7.  Human-induced pluripotent stem cell models of inherited cardiomyopathies.

Authors:  Ioannis Karakikes; Vittavat Termglinchan; Joseph C Wu
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

Review 8.  Human stem cells for modeling heart disease and for drug discovery.

Authors:  Elena Matsa; Paul W Burridge; Joseph C Wu
Journal:  Sci Transl Med       Date:  2014-06-04       Impact factor: 17.956

Review 9.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Authors:  Ian Y Chen; Elena Matsa; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419

Review 10.  Developments with 3D bioprinting for novel drug discovery.

Authors:  Aishwarya Satpathy; Pallab Datta; Yang Wu; Bugra Ayan; Ertugrul Bayram; Ibrahim T Ozbolat
Journal:  Expert Opin Drug Discov       Date:  2018-11-01       Impact factor: 6.098
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.